Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 452.00 | 312.00 | 1.4487 | 1.8753 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 421.00 | 312.00 | 1.3494 | 1.6820 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 401.00 | 312.00 | 1.2853 | 1.5572 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 374.00 | 312.00 | 1.1987 | 1.3884 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 312.50 | 153.73 | 377.00 | 312.00 | 1.2083 | 1.4072 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 248.00 | 312.00 | 0.7949 | 0.5973 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 312.50 | 153.73 | 347.00 | 312.00 | 1.1122 | 1.2195 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 126.00 | 312.00 | 0.4039 | -0.1770 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 317.00 | 312.00 | 1.0160 | 1.0314 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 343.00 | 312.00 | 1.0994 | 1.1944 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 227.00 | 312.00 | 0.7276 | 0.4648 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 292.00 | 312.00 | 0.9359 | 0.8744 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 254.00 | 312.00 | 0.8141 | 0.6352 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 300.00 | 312.00 | 0.9615 | 0.9246 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 315.00 | 312.00 | 1.0096 | 1.0188 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 144.00 | 312.00 | 0.4615 | -0.0620 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 154.00 | 312.00 | 0.4936 | 0.0017 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 359.00 | 312.00 | 1.1506 | 1.2946 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 387.00 | 312.00 | 1.2404 | 1.4697 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 410.00 | 312.00 | 1.3141 | 1.6134 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 128.00 | 312.00 | 0.4103 | -0.1642 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 350.00 | 312.00 | 1.1218 | 1.2382 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 341.00 | 312.00 | 1.0929 | 1.1819 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 396.00 | 312.00 | 1.2692 | 1.5259 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 418.00 | 312.00 | 1.3397 | 1.6633 |